Trial Information
Inclusion Criteria:
- Polycystic Ovary Syndrome
- Age >18 and <35
Exclusion Criteria:
- Chronic or acute inflammatory disease, cancer, autoimmune disease, treatment during
the last 6 months prior to our evaluation, DM2, hypertension, major surgery in the
last 3 months or other hormonal dysfunctions (hypothalamic, pituitary, thyroidal, or
adrenal causes).
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Outcome Measure:
CD4+ CD28 null T-lymphocyte frequency
Outcome Time Frame:
five minutes
Safety Issue:
Yes
Authority:
Italy: National Institute of Health
Study ID:
disfunzionale12
NCT ID:
NCT01574261
Start Date:
March 2012
Completion Date:
Related Keywords:
- Polycystic Ovary Syndrome
- Polycystic Ovary Syndrome
- Cardiovascular risk
- Metabolic Syndrome
- Polycystic Ovary Syndrome